![Daniel Bell](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Daniel Bell
Keine laufenden Positionen mehr
Profil
Daniel Bell was the founder who had held the title of Chief Operating & Financial Officer at Bell Biosystems, Inc. which was founded in 2009.
He received an undergraduate degree from Drexel University.
Ehemalige bekannte Positionen von Daniel Bell
Unternehmen | Position | Ende |
---|---|---|
Bell Biosystems, Inc.
![]() Bell Biosystems, Inc. BiotechnologyHealth Technology Bell Biosystems, Inc. operates as a synthetic biology company. It develops Magnelle, a synthetic organelle that produces magnetic nanoparticles from intracellular iron, as well as enables to track, control, and destroy transplanted cells in vivo. The firm's product is used in regenerative medicine, oncology, and other cell-based fields. The company was founded by Caleb B. Bell III and Daniel Bell in June 2009 and is headquartered in San Francisco, CA. | Gründer | - |
Ausbildung von Daniel Bell
Drexel University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 1 |
---|---|
Bell Biosystems, Inc.
![]() Bell Biosystems, Inc. BiotechnologyHealth Technology Bell Biosystems, Inc. operates as a synthetic biology company. It develops Magnelle, a synthetic organelle that produces magnetic nanoparticles from intracellular iron, as well as enables to track, control, and destroy transplanted cells in vivo. The firm's product is used in regenerative medicine, oncology, and other cell-based fields. The company was founded by Caleb B. Bell III and Daniel Bell in June 2009 and is headquartered in San Francisco, CA. | Health Technology |